Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Morishima

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 11, 1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]N Hirabayashi, S Goto, Y Morishima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|June 1, 1979
[Clinical features of adult patients with acute lymphocytic leukemia according to immunological phenotypes of lymphoblasts (author's transl)]K Kawashima, K Yamada, Y Morishima, et al.
International Journal of Immunogenetics|January 3, 2013
16th IHIW: international histocompatibility working group in hematopoietic cell transplantationE W Petersdorf, M Malkki, K Hsu, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Leukemia|October 18, 2016
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantationJ Kanda, Y Morishima, S Terakura, et al.
Bone Marrow Transplantation|September 24, 2013
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationH Kanamori, S Mizuta, S Kako, et al.
Bone Marrow Transplantation|April 9, 2013
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemiaS Kurosawa, K Yakushijin, T Yamaguchi, et al.
Bone Marrow Transplantation|September 12, 2012
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome RegistryS Kurosawa, K Yakushijin, T Yamaguchi, et al.
Japanese Journal of Clinical Oncology|July 27, 1999
A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study GroupM Narabayashi, K Takeyama, T Fukutomi, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 11, 1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]N Hirabayashi, S Goto, Y Morishima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|June 1, 1979
[Clinical features of adult patients with acute lymphocytic leukemia according to immunological phenotypes of lymphoblasts (author's transl)]K Kawashima, K Yamada, Y Morishima, et al.
International Journal of Immunogenetics|January 3, 2013
16th IHIW: international histocompatibility working group in hematopoietic cell transplantationE W Petersdorf, M Malkki, K Hsu, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Leukemia|October 18, 2016
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantationJ Kanda, Y Morishima, S Terakura, et al.
Bone Marrow Transplantation|September 24, 2013
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationH Kanamori, S Mizuta, S Kako, et al.
Bone Marrow Transplantation|April 9, 2013
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemiaS Kurosawa, K Yakushijin, T Yamaguchi, et al.
Bone Marrow Transplantation|September 12, 2012
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome RegistryS Kurosawa, K Yakushijin, T Yamaguchi, et al.
Japanese Journal of Clinical Oncology|July 27, 1999
A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study GroupM Narabayashi, K Takeyama, T Fukutomi, et al.
Pageof 34